Table 1. Demographic, clinicopathologic and treatment characteristics.

Characteristics	Mitomycin C, n=21 [%]	Platinum, n=13 [%]
Mean age (y)	59	52
Histology
Papillary serous	19 [90]	9 [69]
Clear cell	0	1 [8]
Mucinous	1 [5]	2 [15]
Endometrioid	0	1 [8]
Adenosquamous	1 [5]	0
Initial disease stage
IC	0	1 [8]
IIC	0	2 [15]
IIIA	1 [5]	0
IIIB	0	1 [8]
IIIC	12 [57]	8 [62]
IV	4 [19]	1 [8]
Not fully staged	4 [19]	0
Tumor grade at diagnosis
1	1 [5]	0
2	0	2 [15]
3	19 [90]	8 [62]
Low malignant potential	1 [5]	0
Unknown	0	3 [23]
Indication for HIPEC
Primary treatment	3 [14]
Consolidation therapy	5 [24]	3 [23]
First recurrence	7 [33]	7 [54]
Second recurrence	6 [29]	3 [23]
Mean EBL at time of HIPEC surgery, mL [range]	336 [100-800]	257 [50-750]
Mean operating time, min [range]	378 [233-528]	311 [192-640]

HIPEC, hyperthermic intraperitoneal chemotherapy; EBL, estimated blood loss.